Showing 1 - 20 results of 23 for search 'S. Alimam', query time: 0.08s
Refine Results
-
1
-
2
-
3
THE EFFECTE OF APPLYING COOPERATIVE LEARNING ON OBTAINING AND CERTAIN BASIC SKILLS OF BADMINTON SPORT by Safa Alimam, Ayad Mahmood, Intidhar Ilyas
Published 2011-06-01
Article -
4
-
5
-
6
Rooting Behavior of Six Grape Cultivars (Vitis vinifera L.) Using Indole Butyric Acid by Nabil M. Ameen Alimam, Neam Saif Aldeen Agha
Published 2021-03-01
Article -
7
Detection of a new Apicomplexa group from buffaloes in Mosul city, Iraq by B. A. Albadrani, H. MS. Alimam, Q. T. Al-Obaidi
Published 2023-03-01Article -
8
-
9
-
10
-
11
Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. by Alimam, S, Bewley, S, Chappell, L, Knight, M, Seed, P, Gray, G, Harrison, C, Robinson, S
Published 2016Journal article -
12
Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study by Alimam, S, Bewley, S, Chappell, L, Knight, M, Seed, P, Gray, G, Harrison, C, Robinson, S
Published 2016Journal article -
13
-
14
-
15
An Assessment of the Longitudinal Construct Validity of the Pain Behavioral Scale (PaBS) in a Saudi Population with Chronic Low Back Pain: A Preliminary Study by Dalia Alimam, Ahmed Alhowimel, Faris Alodaibi, Mazyad Alotaibi, Hosam Alzahrani, Nouf Almutairi, Ali Alqahtani, Lolwah Alrashed Alhumaid, Andrew Leaver, Martin Mackey
Published 2023-06-01
Article -
16
Longitudinal mutational analysis in hydroxycarbamide-resistant/intolerant essential thrombocythemia treated on the majic-ET study by O'Sullivan, J, Hamblin, A, Panchal, A, Yap, C, Fox, S, Alimam, S, Dreau, H, Howard, K, Ware, P, Baker, S, Cross, N, McMullin, M, Harrison, C, Mead, A
Published 2018Conference item -
17
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib by O'Sullivan, JM, Hamblin, A, Yap, C, Fox, S, Boucher, R, Panchal A, Alimam, S, Dreau, H, Howard, K, Ware, P, Cross, NCP, McMullin, MF, Harrison, CN, Mead, AJ
Published 2019Journal article -
18
Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial by Harrison, C, Mead, A, Panchal, A, Fox, S, Yap, C, Gbandi, E, Houlton, A, Alimam, S, Ewing, J, Wood, M, Chen, F, Coppell, J, Panoskaltsis, N, Knapper, S, Ali, S, Hamblin, A, Scherber, R, Dueck, A, Cross, N, Mesa, R, McMullin, M
Published 2017Journal article -
19
S199: A NATIONAL RETROSPECTIVE COHORT STUDY OF MPN-SVT: RESULTS FROM THE UK MYELOPROLIFERATIVE NEOPLASMS ASSOCIATED SPLANCHNIC VEIN THROMBOSIS (MASCOT) REGISTRY by R. Hargreaves, M. Subhan, S. Alimam, S. Shapiro, A. Robinson, M. Carter, A. Godfrey, M. Ul-Haq, M. Jain, G. Greenfield, A. McGregor, H. K. Hussein, D. Tripathi, H. Network, A. Doyle, K. White, N. Curto-Garcia, D. Patch, M. Sekhar
Published 2022-06-01
Article -
20
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar by Ahmed Zaqout, Muna A. Almaslamani, Hiam Chemaitelly, Samar A. Hashim, Ajithkumar Ittaman, Abeir Alimam, Fatma Rustom, Joanne Daghfal, Mohammed Abukhattab, Sawsan AlMukdad, Anvar Hassan Kaleeckal, Ali Nizar Latif, Adeel A. Butt, Roberto Bertollini, Abdullatif Al-Khal, Ali S. Omrani, Laith J. Abu-Raddad
Published 2022-11-01
Article